An Van Den Bulcke, Ph.D. – Innovation leader in polymers, biomedical materials, and technology commercialisation. Former Senior Business Developer at Ghent University, driving biomedical research to market through industrial partnerships, IP strategy, licensing, and spin-off creation. Co-founded AVROXA (2018), delivering high-quality poly(2-oxazoline)s, and shaped BIOINX’s early business strategy (inc. 2022). Since 2023, COO and co-founder of 4TISSUE, specialising in clinical validation of novel hydrogels and tissue mimics for regenerative medicine. Lead product: minimally invasive breast reconstruction solution. Combines deep scientific expertise with strategic business execution to accelerate innovation from lab to market.